Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€98.38

€98.38

1.190%
1.16
1.190%
€115.92
 
07:41 / Tradegate WKN: A2PH5P / Symbol: TMDX / Name: Transmedics Group / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Transmedics Group Inc Stock

There is an upward development for Transmedics Group Inc compared to yesterday, with an increase of €1.16 (1.190%).
With 18 Buy predictions and not the single Sell prediction the community is currently very high on Transmedics Group Inc.
With a target price of 115 € there is a slightly positive potential of 16.89% for Transmedics Group Inc compared to the current price of 98.38 €.
So far the community has only identified positive things for Transmedics Group Inc stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Transmedics Group Inc in the next few years

Pros
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) 0.84%
Target price 131.719
Change
Ends at 16.09.26

TransMedics Group (NASDAQ:TMDX) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $155.00 price target on the stock.
Ratings data for TMDX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -19.69%
Target price 129.840
Change
Ends at 17.06.26

TransMedics Group, Inc. (NASDAQ: TMDX) had its price target raised by analysts at Oppenheimer Holdings Inc. from $130.00 to $150.00. They now have an "outperform" rating on the stock.
Ratings data for TMDX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -14.12%
Target price 127.339
Change
Ends at 04.06.26

TransMedics Group, Inc. (NASDAQ: TMDX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $145.00 price target on the stock, up previously from $125.00.
Ratings data for TMDX provided by MarketBeat
Show more